2023 Annual Equity Distribution Implementation Notice
Announcement on the company\'s 2023 profit distribution plan
Announcement on the Listing of Part of the Restricted Shares for the First Time
Announcement on the dilution immediate return and filling measures, as well as related subject commitments for the issuance of A shares to specific targets in 2024.
The written review opinion of the supervisory board regarding the issuance of A-shares to specific objects for the year 2024.
Shareholder dividend return plan for the next three years (2024-2026).
Plan to issue A shares of stocks to specific entities in 2024.
Feasibility analysis report for issuing A shares of stocks to specific objects in 2024
Feasibility analysis report of using funds raised from the issuance of A shares to specific objects in 2024.
Notice of Disclosure of the Proposed Issuance of A-Stocks to Specific Objects in 2024.
Announcement on the company's 2023 profit distribution plan
2022 Annual Equity Distribution Implementation Notice
Legal opinion of Beijing Kangda Law Firm on the 2023 Restricted Stock Incentive Plan of Hunan Huana Pharmaceutical Co., Ltd.
2023 Restricted Stock Incentive Plan (Draft) Summary Announcement
Announcement on the company\'s 2022 annual profit distribution plan
Audit opinions of the Supervisory Board on matters relating to the company\'s 2023 restricted stock incentive plan
List of incentive recipients granted for the first time in the 2023 Restricted Stock Incentive Plan
2023 Restricted Stock Incentive Plan (Draft)
Initial Public Offering Strategic Placement of Restricted Shares Listing and Circulation Notice
Announcement of the results of shareholders' and directors' and supervisors' shareholding reduction
No Data
No Data